Traws Pharma Inc. (NASDAQ : TRAW) Stock

MWN-AI** Summary

MWN-AI** Analysis

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Description

Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab.

Quote

Last:	$1.2818
Change Percent:	3.37%
Open:	$1.28
Close:	$1.24
High:	$1.31
Low:	$1.25
Volume:	112,879
Last Trade Date Time:	06/12/2026 12:36:54 pm

Stock Data

Market Cap:	$15,422,373
Float:	6,872,146
Insiders Ownership:	2.64%
Institutions:	11
Short Percent:	N/A
Industry:	Biotechnology & Life Sciences
Sector:	Healthcare
Website:	https://www.trawspharma.com
Country:	US
City:	Newtown